利益相关者对儿童随机临床试验的观点 预后不佳的癌症
Nicholas Bird1,2, Nicole Scobie2,3, Pablo Berlanga4
1Solving Kids' Cancer UK, London, United Kingdom.
JAMA network open
|December 6, 2024
概括
对预后不佳的儿童癌症的新疗法需要仔细评估. 共识建议指导随机临床试验 (RCT) 的使用,以确保在儿童癌症药物开发中满足患者的需求.
科学领域:
- 儿科瘤学 儿科瘤学
- 临床试验设计 临床试验设计
- 药物开发 药物开发
背景情况:
- 新疗法为预后不佳的儿童癌症提供了希望,但需要严格的评估.
- 随机临床试验 (RCT) 是评估新疗法的黄金标准.
- 对于儿童癌症药物开发的最佳RCT实施,缺乏共识.
研究的目的:
- 促进利益相关者之间关于儿童癌症新疗法的RCT的共享理解.
- 制定关于在这个人群中适当使用RCT的共识建议.
主要方法:
- 召开了两次结构化研讨会,与各种利益相关者 (患者倡导者,研究人员,监管机构,HTA机构) 合作.
- 利用了会议前的材料,专家演讲和专注的讨论.
- 通过合作起草和修订过程,就建议达成共识.
主要成果:
- 制定了八项共识建议,解决了RCT的关键方面.
- 建议强调早期战略制定,利益相关者参与和患者关注.
- 关于试验时间,交叉使用,终点,对照组和生活质量指标的具体指导.
结论:
- 该共识为儿童瘤学的未来药物开发提供了一个框架.
- 从一开始就整合利益相关者的观点对于有效的试验设计至关重要.
- 这些建议旨在在儿科癌症研究中平衡科学严谨性和以患者为中心的结果.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Longitudinal Research
11.8K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.8K


